Evidence map›Paper›PMID 31886311›Full record

ReviewJournal of immunology research2019

Advances in the Research on Anticardiolipin Antibody.

Dan Wang, Wenxin Lv, Shichang Zhang, Jiexin Zhang

Open access · goldAbstract readReview
In one paragraph

Review in Journal of immunology research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Overlapping Clinical Presentation of Long COVID and Postacute COVID-19 Vaccination Syndrome: Phenotypes, Severity, and Biomarkers.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  2. Article
  3. B Cell Tolerance and Obstetric Antiphospholipid Syndrome.Clinical reviews in allergy & immunology · 2025
    Review
  4. A case series on TNF-α inhibitors for APS- induced high-risk pregnancies.Journal of clinical and translational science · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Thrombosis associated withExperimental and therapeutic medicine · 2021
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Dan WangDepartment of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, China.ORCID https://orcid.org/0000-0002-8186-5932
Wenxin LvDepartment of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, China.ORCID https://orcid.org/0000-0002-3366-5274
Shichang ZhangDepartment of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, China.ORCID https://orcid.org/0000-0002-6587-2518
Jiexin ZhangDepartment of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, China.ORCID https://orcid.org/0000-0003-1407-7562
Jiangsu Province Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anticardiolipin antibody (ACA) is a kind of autoantibody and is one of the antiphospholipid antibodies (aPLs). Phospholipids with a negative charge on platelets and endothelial cell membranes are ACA target antigens. ACA is common in systemic lupus erythematosus and other autoimmune diseases and is closely associated with thrombosis, thrombocytopenia, and spontaneous abortion. In 1983, Harris established a method for detecting ACA, and research on the antibody has gained worldwide attention and has developed rapidly. For this review, we browsed articles that cover most of the ACA-related studies in the last 25 years and extracted influential ideas and conclusions in this field.

Indexed as

Disease SusceptibilityResearchAntibodies, AnticardiolipinAutoantigensAutoimmune DiseasesBiomarkersCardiolipinsDisease ManagementHumansAntibodies, AnticardiolipinAutoantigensBiomarkersCardiolipins

Identifiers

PMID31886311
PMCPMC6914984
OpenAlexW2990759799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.